MedPath

Onnit Labs New Mood Supplementation in Healthy College Students

Not Applicable
Completed
Conditions
Mental Health Wellness 1
Interventions
Dietary Supplement: Multi-Ingredient Herbal Supplement
Dietary Supplement: Placebo Supplement
Registration Number
NCT05109923
Lead Sponsor
University of Idaho
Brief Summary

The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan. 5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Currently enrolled collegiate men and women at the University of Idaho
Exclusion Criteria
  • Currently taking mood or sleep enhancing supplementation/medication
  • Currently participating in counseling and/or therapy sessions
  • Previously diagnosed with a psychological disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
New Mood SupplementationMulti-Ingredient Herbal SupplementThe New Mood herbal supplement includes lemon balm, 5-HPT, L-Tryptophan and valerian root.
Placebo SupplementationPlacebo SupplementThe placebo includes rice bran and maltodextrin.
Primary Outcome Measures
NameTimeMethod
Change in resting heart rate (beats per minute) over 8 weeksChange from baseline resting heart rate (beats per minute) response at 8 weeks

Manual radial pulse measurement of resting heart rate (beats per minute) at baseline and 8 weeks

Change in resting systolic and diastolic blood pressure (mm Hg) over 8 weeksChange from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks

Digital sphygmomanometer measurement of resting systolic and diastolic blood pressure (mm Hg) at baseline and 8 weeks

Change in depression, anxiety and stress scores (0-34) over 8 weeksChange from baseline DASS-21 score at 8 weeks

Depression, Anxiety and Stress Scale Questionnaire (DASS-21, 0-34) to assess depression, anxiety and stress scores from baseline to 8 weeks

Change in cortisol awakening response (mg/dL) over 8 weeksChange from baseline cortisol awakening response (mg/dL) at 8 weeks

Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Idaho

🇺🇸

Moscow, Idaho, United States

© Copyright 2025. All Rights Reserved by MedPath